Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)

Clinical trial NCT06980948 · RECRUITING

Trial details

NCT number: NCT06980948
Sponsor: Sangamo Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Neuropathic Pain

Start date: 2025-12-04
Primary completion: 2027-07-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.